JPS6143360B2 - - Google Patents
Info
- Publication number
- JPS6143360B2 JPS6143360B2 JP2075578A JP2075578A JPS6143360B2 JP S6143360 B2 JPS6143360 B2 JP S6143360B2 JP 2075578 A JP2075578 A JP 2075578A JP 2075578 A JP2075578 A JP 2075578A JP S6143360 B2 JPS6143360 B2 JP S6143360B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- enzyme
- ester
- substrate
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000790 Enzymes Proteins 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 14
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims description 13
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 238000006482 condensation reaction Methods 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 238000000691 measurement method Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 29
- 239000000243 solution Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 11
- 150000002148 esters Chemical class 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- -1 ester compound Chemical class 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 108090000190 Thrombin Proteins 0.000 description 7
- 229960004072 thrombin Drugs 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- 150000004702 methyl esters Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960005356 urokinase Drugs 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 108010028774 Complement C1 Proteins 0.000 description 1
- 102100025406 Complement C1s subcomponent Human genes 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical class [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108010076857 N(alpha)-acetylglycyllysyl methyl ester Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FKMJXALNHKIDOD-LBPRGKRZSA-N TAMe Chemical compound NC(=N)NCCC[C@@H](C(=O)OC)NS(=O)(=O)C1=CC=C(C)C=C1 FKMJXALNHKIDOD-LBPRGKRZSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000006149 azo coupling reaction Methods 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- HLVXFWDLRHCZEI-UHFFFAOYSA-N chromotropic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(O)=CC(S(O)(=O)=O)=CC2=C1 HLVXFWDLRHCZEI-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FIGKGJVUYAFLBI-VIFPVBQESA-N methyl (2s)-2-[(2-acetamidoacetyl)amino]-6-aminohexanoate Chemical compound NCCCC[C@@H](C(=O)OC)NC(=O)CNC(C)=O FIGKGJVUYAFLBI-VIFPVBQESA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】
本発明は式()で示されるアミノ酸誘導体、
その製造法、及びその化合物を基質として酵素活
性を測定する方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides an amino acid derivative represented by the formula (),
The present invention relates to a method for producing the compound and a method for measuring enzyme activity using the compound as a substrate.
式中、Rはナフチル基を示す。 In the formula, R represents a naphthyl group.
本発明物質()は新規な化合物であり、酵素
活性を測定する為の試験薬として有用な化合物で
ある。 The substance of the present invention () is a novel compound and is a compound useful as a test drug for measuring enzyme activity.
本発明物質()はグリシルリジン誘導体
()とナフトールとの通常の脱水縮合反応によ
り式()で示されるエステル体とし、次いでω
―アミノ基保護基を除去することにより製造する
ことができる。 The substance of the present invention () is formed into an ester body represented by the formula () by a normal dehydration condensation reaction between a glycyrrhizine derivative () and naphthol, and then ω
-Can be produced by removing the amino group protecting group.
式中、Rはナフチル基を示す。R′はアミノ基
保護基を示す。 In the formula, R represents a naphthyl group. R′ represents an amino group-protecting group.
本発明を実施するに当つては、上記グリシルリ
ジン誘導体()とナフトールとの通常の脱水縮
合反応によつてエステル体()を得ることがで
きる。すなわち、グリシルリジン誘導体()を
適当な溶媒に溶解し、DCC(ジシクロヘキシル
カーボジイミド)、DPPA(ジフエニルフオスフ
オリルアジド)、クロル炭酸アルキル等のエステ
ル活性化剤を加えこれにフエノール又はナフトー
ルを加え、必要に応じトリエチルアミン等の塩基
を加え、撹拌することにより製造することができ
る。又、良く知られた酸クロライド法や、ナフト
ールのスルフイツト体としてよく知られたナフチ
ル化剤(Ber.49,2339,1916)を用いることによ
つても製造することができる。 In carrying out the present invention, the ester compound () can be obtained by a conventional dehydration condensation reaction between the glycyrrhizine derivative () and naphthol. That is, a glycyrrhizine derivative () is dissolved in a suitable solvent, an ester activator such as DCC (dicyclohexylcarbodiimide), DPPA (diphenylphosphoryl azide), or alkyl chlorocarbonate is added thereto, and phenol or naphthol is added thereto. It can be produced by adding a base such as triethylamine if necessary and stirring. It can also be produced by the well-known acid chloride method or by using a well-known naphthylating agent (Ber. 49 , 2339, 1916) as a sulfite form of naphthol.
使用し得る溶媒は、クロロホルム、ジクロルメ
タン、ジメチルホルムアミド、テトラヒドロフラ
ン等通常使用されるもので、原料物質を溶解する
ものであれば良い。反応温度は0゜〜40℃で良
い。 Usable solvents include commonly used solvents such as chloroform, dichloromethane, dimethylformamide, and tetrahydrofuran, as long as they can dissolve the raw material. The reaction temperature may be 0° to 40°C.
反応終了後、通常行われる処理方法により、反
応液よりエステル体()を得ることができる。
すなわち、例えばDCCを縮合剤として製造した
場合、析出するジシクロヘキシル尿素を濾取して
除き、塩酸水溶液、NaOH水溶液、及び飽和食塩
水で洗浄し、無水硫酸マグネシウム等の乾燥剤で
乾燥後、溶媒を留去することにより得ることがで
きる。エステル体()は所望により、再結晶、
クロマトグラフイー等により精製することができ
る。 After the reaction is completed, the ester () can be obtained from the reaction solution by a commonly used treatment method.
That is, for example, when DCC is produced as a condensing agent, precipitated dicyclohexyl urea is removed by filtration, washed with an aqueous hydrochloric acid solution, an aqueous NaOH solution, and a saturated saline solution, dried with a drying agent such as anhydrous magnesium sulfate, and then the solvent is removed. It can be obtained by distillation. The ester () may be recrystallized if desired.
It can be purified by chromatography or the like.
通常の反応でアミノ基保護基を除去することに
よりエステル体()より目的化合物()を得
ることができる。すなわち、例えばアミノ基保護
基がカルボベンジルオキシ基の場合、()を適
当な溶媒に溶解しパラジウム炭素等の触媒で還元
的に除去するか、()を臭化水素酸酢酸溶液に
加え析出する目的化合物の臭化水素酸塩を取す
ることにより得ることができる。 The target compound () can be obtained from the ester () by removing the amino group-protecting group in a normal reaction. That is, for example, when the amino group-protecting group is a carbobenzyloxy group, () is dissolved in a suitable solvent and reductively removed using a catalyst such as palladium on carbon, or () is added to a hydrobromide-acetic acid solution and precipitated. It can be obtained by removing the hydrobromide salt of the target compound.
本発明物質()は、酵素と接触させることに
より基質として働き、一定時間後酵素により水解
されて遊離したナフトールを測定することによ
り、酵素の活性を測定することが出来る。酵素の
活性を測定するということは酵素製剤の規格、血
中酵素パターンの測定による診断、血中酵素濃度
の測定等の為に非常に重要なことである。 The substance of the present invention () acts as a substrate when brought into contact with an enzyme, and after a certain period of time, it is hydrolyzed by the enzyme and liberated naphthol is measured, thereby making it possible to measure the activity of the enzyme. Measuring enzyme activity is very important for purposes such as standardization of enzyme preparations, diagnosis by measuring blood enzyme patterns, and measurement of blood enzyme concentration.
従来、酵素活性を測定するためには種々の方法
が知られている。その一つの方法として、アミノ
酸のアルキルエステルを基質として、酵素と接触
させ、そのエステルの水解の程度により活性を測
定するという方法がある。例えば、ヘステリン法
として良く知られている方法がその一つである。
これは、酵素とアミノ酸のアルキルエステルを接
触させ、一定時間後に残存するエステル部分をヒ
ドロキシアミンによりヒドロキサム酸とし、塩化
第二鉄と反応させ発色させ、その発色を吸光度と
して測定し、その結果より、酵素のエステル水解
能、すなわち、酵素の活性を測定するという方法
である。 Conventionally, various methods are known for measuring enzyme activity. One method is to use an alkyl ester of an amino acid as a substrate, contact it with an enzyme, and measure the activity based on the degree of hydrolysis of the ester. For example, a method well known as the Hesterin method is one of them.
This is done by bringing an enzyme into contact with an alkyl ester of an amino acid, converting the remaining ester portion after a certain period of time into hydroxamic acid using hydroxyamine, reacting with ferric chloride to develop a color, and measuring the color development as absorbance. Based on the results, This method measures the ester water-degrading ability of an enzyme, that is, the activity of the enzyme.
その他、基質を用いエステルの水解能を指標と
する方法には、クロモトロプ酸法などがあるが、
これらの方法では、ある程度の酵素量を必要と
し、酵素が低濃度である場合、又は低活性の酵素
の測定には難があつた。そこで、発明者は、酵素
に対してアフイニテイを持ち、更に定量法が簡便
であり、かつ検出感度の良いという三つの条件を
兼ね備えた基質としての化合物を検索することに
より、従来よりも、非常に優れた化合物、及びそ
の方法を見出すことができた。 Other methods that use a substrate and use the water-dissolving ability of esters as an index include the chromotropic acid method.
These methods require a certain amount of enzyme and are difficult to measure when the enzyme is at a low concentration or has low activity. Therefore, the inventor searched for a compound as a substrate that had affinity for the enzyme, was easy to quantify, and had high detection sensitivity. We were able to discover an excellent compound and its method.
本発明を実施するに当つては、酵素と一定量の
化合物()を、適当な緩衝液中で接触させ、一
定温度で、一定時間後に遊離したナフトールを測
定することにより、酵素の活性を測定することが
できる。 In carrying out the present invention, the activity of the enzyme is measured by bringing the enzyme and a certain amount of the compound () into contact with each other in a suitable buffer solution, and measuring the liberated naphthol after a certain period of time at a certain temperature. can do.
緩衝液はその酵素の至適PHを有する適当な緩衝
液でよい。又、反応温度、反応時間ともに適当な
一定条件でよいが、25〜37℃で30分後に測定する
のが望ましい。 The buffer may be a suitable buffer having the optimum pH of the enzyme. Further, the reaction temperature and reaction time may be set under any suitable constant conditions, but it is preferable to measure after 30 minutes at 25 to 37°C.
ナフトールを測定する法は従来、良く知られた
ガスクロマトグラフイーは薄層クロマトグラフイ
ー等の物理化学的方法塩化第二鉄反応、ジアゾカ
ツプリング反応、またはFVB(フアーストバイ
オレツトBソルト)法等の化学的方法のいずれか
の方法を使用してもよいが、反応後にFVBを加
え発色させ分光光度計により吸光度として測定す
る方法がその簡便さおよび検出感度においてより
好ましい方法である。本法は単一酵素系における
測定のみならず種々の酵素が含まれた場合の測定
にも使用できる。すなわち、例えば血清中に含ま
れる酵素活性を測定する場合、血清を適当なプレ
パラートに添加し、これを電気泳動等により酵素
を分解し、これを本発明物質の溶液に浸し適当な
時間後、更に上記発色試薬を加えることにより、
従来見ることができなかつた血中酵素パターンを
見ることができる。この方法によれば、種々の病
態に起因する酵素パターンの変動を見ることがで
きる。 Conventional methods for measuring naphthol include physicochemical methods such as well-known gas chromatography and thin layer chromatography, ferric chloride reaction, diazo coupling reaction, or FVB (first violet B salt) method. Although any of the above chemical methods may be used, a method in which FVB is added after the reaction to develop a color and measured as absorbance using a spectrophotometer is a more preferable method in terms of simplicity and detection sensitivity. This method can be used not only for measurements in a single enzyme system but also for measurements involving various enzymes. That is, for example, when measuring the enzyme activity contained in serum, the serum is added to an appropriate preparation, the enzymes are decomposed by electrophoresis, etc., and this is immersed in a solution of the substance of the present invention, and after an appropriate time, further By adding the above coloring reagent,
Enzyme patterns in the blood that were previously impossible to see can be seen. According to this method, changes in enzyme patterns caused by various pathological conditions can be observed.
本発明物質はトリプシン、プラスミン、カリク
レイン、ウロキナーゼ、C1エステラーゼ、スロ
ンビン等種々の酵素の優れた基質として作用し特
にアセチルグリシルリジンナフチルエステルを基
質として酵素活性を測定した場合、従来、酵素基
質として知られたアセチルグリシルリジンメチル
エステル、トシルアルギニンメチルエステルを用
い、ヘステリン法により測定した場合に比べ、3
倍ないし550倍の検出感度を有していた。 The substance of the present invention acts as an excellent substrate for various enzymes such as trypsin, plasmin, kallikrein, urokinase, C1 esterase, and thrombin, and in particular when enzyme activity is measured using acetylglycyrrhizine naphthyl ester as a substrate, 3 compared to when measured by the hesterin method using acetylglycyrrhizine methyl ester and tosylarginine methyl ester.
The detection sensitivity was between 550 times and 550 times higher.
次に実施例を掲げ、更に詳細に説明する。 Next, examples will be given and explained in more detail.
実施例 1
N―アセチルグリシルリジンナフチルエステル
の合成
アセチルグリシル―ε―カルボベンジルオキシ
リジンメチルエステル(Biophys Acta.,132,
104〜114(1967)7.6gをメタノール100mlに溶か
しN―NaOH30mlを加え室温で2時間撹拌する。
反応液に酢酸エステルと水を加え、振とうし、水
層を10%塩酸溶液で酸性として析出する油状物を
酢酸エステルで4回抽出する。酢酸エステル溶液
を飽和食塩水で洗浄した後、硫酸マグネシウムで
乾燥した後、減圧濃縮し、アセチルグリシル―ε
―カルボベンジルオキシリジンを結晶状粉末とし
て得る。Example 1 Synthesis of N-acetylglycyrrhizine naphthyl ester Acetylglycyl-ε-carbobenzyloxylysine methyl ester (Biophys Acta., 132,
Dissolve 7.6 g of 104-114 (1967) in 100 ml of methanol, add 30 ml of N-NaOH, and stir at room temperature for 2 hours.
Acetate and water are added to the reaction solution, shaken, and the aqueous layer is acidified with 10% hydrochloric acid solution, and the precipitated oil is extracted four times with acetate. After washing the acetate ester solution with saturated saline, drying with magnesium sulfate, and concentrating under reduced pressure, acetylglycyl-ε
- Carbobenzyloxylysine is obtained as a crystalline powder.
収量5.8g 収率75% 融点112〜4゜
IR(KBr,cm-1)3375,3275,3250(NH),1750
(CO),1690(NHCOO),1640(NHCO)
元素分析 C18H25N3O6(MW379.40)として
理論値 C,56.98,H,6.64,N,11.08
実測値 C,56.41,H,6.60,N,10.80
アセチルグリシル―ε―カルボベンジルオキシ
リジン3.6gをとり、N,Nジメチルホルムアミ
ド20mlに溶かし、αナフトール1.4g、N,N′ジ
シクロヘキシルカーボジイミド2.4gトリエチル
アミン1.4mlと共に1昼夜撹拌する、反応液に酢
酸エステルを加え、10%クエン酸溶液、飽和重そ
う水、飽和食塩水で順次洗浄後、硫酸マグネシウ
ムで乾燥、減圧濃縮して析出する粉末を集め、酢
酸エステルより再結晶しN―アセチルグリシル―
ε―カルボベンジルオキシリジン―α―ナフチル
エステルを得る。Yield 5.8g Yield 75% Melting point 112~4゜IR (KBr, cm -1 ) 3375, 3275, 3250 (NH), 1750
(CO), 1690 (NHCOO), 1640 (NHCO) Elemental analysis C 18 H 25 N 3 O 6 (MW379.40) Theoretical value C, 56.98, H, 6.64, N, 11.08 Actual value C, 56.41, H, 6.60, N, 10.80 Take 3.6 g of acetylglycyl-ε-carbobenzyloxylidine, dissolve it in 20 ml of N,N dimethylformamide, and stir with 1.4 g of α-naphthol, 2.4 g of N,N' dicyclohexylcarbodiimide, and 1.4 ml of triethylamine for one day and night. Add acetate to the reaction solution, wash sequentially with 10% citric acid solution, saturated deuterated water, and saturated brine, dry over magnesium sulfate, concentrate under reduced pressure, collect the precipitated powder, and recrystallize from acetate. N-acetylglycyl-
ε-carbobenzyloxylysine-α-naphthyl ester is obtained.
収量2.5g 収率52% 融点103〜50
IR(KBr,cm-1)3325(NH)1755(CO)1680,
1640(NHCO)
元素分析 C28H31N3O6(MW505.55)として
理論値 C,66.52,H,6.18,N,8.31
実測値 C,66.06,H,6,36,N,7.96
Nアセチルグリシル―ε―カルボベンジルオキ
シリジン―α―ナフチルエステル2.5gを、N,
Nジメチルホルムアミド25mlにとかし、塩酸ガス
―ジオキサン溶液3g(0.06527gHClgas/
g)、10%パラジウム炭素500mgを加え、2時間水
素ガスを導通する。反応後ろ過してパラジウム炭
素を除き、母液に無水エーテルを加え析出する油
状物を集め、さらに酢酸エステルで洗浄しN―ア
セチルグリシルリジンナフチルエステル塩酸塩を
無色油状物として得る、収量1.0g。Yield 2.5g Yield 52% Melting point 103-50 IR (KBr, cm -1 ) 3325 (NH) 1755 (CO) 1680,
1640 (NHCO) Elemental analysis C 28 H 31 N 3 O 6 (MW505.55) Theoretical value C, 66.52, H, 6.18, N, 8.31 Actual value C, 66.06, H, 6, 36, N, 7.96 N acetyl 2.5 g of glycyl-ε-carbobenzyloxylysine-α-naphthyl ester was added to N,
Dissolve in 25 ml of N dimethylformamide and add 3 g of hydrochloric acid gas-dioxane solution (0.06527 g HClgas/
g) Add 500 mg of 10% palladium on carbon and pass hydrogen gas through for 2 hours. After the reaction, the palladium on carbon was removed by filtration, and anhydrous ether was added to the mother liquor to collect the precipitated oil, which was further washed with acetic acid ester to obtain N-acetylglycyrrhizine naphthyl ester hydrochloride as a colorless oil, yield 1.0 g.
IR(ueat,cm-1)3250(NH),2950(NH3 +)1750
(COO)1630(NHCO)
実施例 2
N―アセチルグリシルリジンナフチルエステル
を基質としたスロンビンの活性測定法
スロンビンの希釈液0.5mlにN―アセチルグリ
シルリジンナフチルエステル溶液(0.5μmole/
0.5ml5%DMSO)0.5ml加え25℃で30分間インキ
ユベートする。これに1%フアーストバイオレツ
トBソルト(FVB)0.1mlを加え0℃で30分間放
置し更に氷酢酸1mlを加え、発色を吸光光度計に
より吸光度(515nm)として測定し、酵素により
水解されて遊離したナフトールを定量する。この
遊離したナフトール量が酵素の活性度である。IR (ueat, cm -1 ) 3250 (NH), 2950 (NH 3 + ) 1750
(COO) 1630 (NHCO) Example 2 Thrombin activity measurement method using N-acetylglycyrrhizine naphthyl ester as a substrate N-acetylglycyrrhizine naphthyl ester solution (0.5 μmole/
Add 0.5 ml of 5% DMSO) and incubate at 25°C for 30 minutes. Add 0.1 ml of 1% first violet B salt (FVB) to this, leave it for 30 minutes at 0°C, then add 1 ml of glacial acetic acid, and measure the color development as absorbance (515 nm) using an absorptiometer. Quantitate liberated naphthol. The amount of liberated naphthol is the activity of the enzyme.
参考例 1
N―アセチルグリシルリジンメチルエステルを
基質としたスロンビンの活性測定法(ヘステリ
ン法)
スロンビンの希釈液にN―アセチルグリシルリ
ジンメチルエステル溶液(10μM/0.4ml5%
DMSO)0.4ml、及びリン酸緩衝液(PH7.4)0.1ml
を加える。37℃で30分間インキユベーシヨンした
後、ヒドロキシルアミン溶液(2M―NH2OHおよ
び3.5M NaOHの等量混合物)1.5ml加え室温で15
分間放置する。これに18%トリクロル酢酸1ml、
4N塩酸1ml、及び10%塩化第二鉄1mlを加え充
分にかくはんした後3000r.p.m.で10分間遠心分離
する。上澄液の発色を分光光度計により吸光度
(530nm)として測定する。この値はスロンビン
によつて水解されずに残つた基質の量に相関する
もので酵素の活性は基質のみの値(対照)から酵
素反応を行なつた後に得られる値を引いた値に相
当する実施例3及び参考例1で測定したスロンビ
ンの各濃度段階における結果を第1図に示すが前
者の方法は後者の方法に比べ50倍の感度を有して
いることが分る。同様にウロキナーゼを測定した
場合N―アセチルグリシルリジンメチルエステル
を基質として用い参考例1の方法で測定した場合
に比べ、11倍、トシルアルギニンメチルエステル
を基質として用い参考例1の方法に従い測定した
場合に比べ、555倍の感度を有していた。Reference example 1 Thrombin activity measurement method using N-acetylglycyrrhizine methyl ester as a substrate (Hesterin method) N-acetylglycyrrhizine methyl ester solution (10 μM/0.4 ml 5%) in the thrombin diluted solution
DMSO) 0.4ml, and phosphate buffer (PH7.4) 0.1ml
Add. After incubation at 37°C for 30 min, 1.5 ml of hydroxylamine solution (equal mixture of 2M-NH 2 OH and 3.5M NaOH) was added and the solution was incubated at room temperature for 15 min.
Leave for a minute. Add 1 ml of 18% trichloroacetic acid to this.
Add 1 ml of 4N hydrochloric acid and 1 ml of 10% ferric chloride, stir thoroughly, and centrifuge at 3000 rpm for 10 minutes. The color development of the supernatant liquid is measured as absorbance (530 nm) using a spectrophotometer. This value correlates to the amount of substrate remaining without being hydrolyzed by thrombin, and the enzyme activity corresponds to the value obtained by subtracting the value obtained after performing the enzyme reaction from the value for substrate only (control). The results at each concentration level of thrombin measured in Example 3 and Reference Example 1 are shown in FIG. 1, and it can be seen that the former method is 50 times more sensitive than the latter method. Similarly, when urokinase was measured, it was 11 times more effective than when measured using N-acetylglycyrrhizine methyl ester as a substrate and using the method of Reference Example 1. It was 555 times more sensitive than the conventional method.
第1図はスロンビン活性を指標とした本願発明
の化合物の効果を示す。
AGLNEはアセチルグリシルリジンナフチルエ
ステルを、AGLMEはアセチルグリシルリジンメ
チルエステルを表わす。
FIG. 1 shows the effects of the compounds of the present invention using thrombin activity as an index. AGLNE represents acetylglycyrrhizine naphthyl ester, and AGLME represents acetylglycyrrhizine methyl ester.
Claims (1)
を通常の脱水縮合反応させることにより式() で示されるエステル体とし次いでω―アミノ保護
基を除去することを特徴とする式()(式中R
はナフチル基、R′はアミノ保護基を示す) で示されるアミノ酸誘導体の製造方法。 3 式() (式中Rはナフチル基を示す)で示されるアミ
ノ酸誘導体を基質として酵素と接触させることを
特徴とする酵素活性の測定方法。 4 式()で示されるアミノ酸誘導体を基質と
して酵素と接触させ、一定時間後、酵素により水
解されて遊離したナフトールを測定することを特
徴とする特許請求の範囲第3項に記載の酵素活性
の測定法。[Claims] 1 Formula () Amino acid derivative represented by. (In the formula, R represents a naphthyl group) 2 Formula () By subjecting the glycyrrhizine derivative shown by the formula () to a normal dehydration condensation reaction with naphthol, the formula () is obtained. Formula () (in the formula, R
is a naphthyl group, R′ is an amino protecting group) A method for producing an amino acid derivative represented by 3 formula () A method for measuring enzyme activity, which comprises bringing an amino acid derivative represented by the formula (R represents a naphthyl group) into contact with an enzyme as a substrate. 4. The method of measuring enzyme activity according to claim 3, characterized in that the amino acid derivative represented by the formula () is brought into contact with an enzyme as a substrate, and after a certain period of time, the naphthol liberated by hydrolysis by the enzyme is measured. Measurement method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2075578A JPS54115332A (en) | 1978-02-24 | 1978-02-24 | Amino acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2075578A JPS54115332A (en) | 1978-02-24 | 1978-02-24 | Amino acid derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS54115332A JPS54115332A (en) | 1979-09-07 |
JPS6143360B2 true JPS6143360B2 (en) | 1986-09-26 |
Family
ID=12035996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2075578A Granted JPS54115332A (en) | 1978-02-24 | 1978-02-24 | Amino acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS54115332A (en) |
-
1978
- 1978-02-24 JP JP2075578A patent/JPS54115332A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS54115332A (en) | 1979-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bieth et al. | The synthesis and analytical use of a highly sensitive and convenient substrate of elastase | |
PL90746B1 (en) | ||
FI85990B (en) | SAMMANSAETTNING INNEHAOLLANDE ZWITTERJONKOPPLINGSMEDEL OCH TESTANORDNING FOER BESTAEMNING AV LEUKOCYTER. | |
US4645842A (en) | Pyrrole compounds for detecting the presence of hydrolytic analytes | |
US5750359A (en) | Composition for detecting leucocyte and proteinase in urine and its measuring device | |
US4704460A (en) | Novel compounds for detecting the presence of hydrolytic analytes in a test sample | |
US4308202A (en) | Prolylphenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same | |
JPS6126917B2 (en) | ||
US4379764A (en) | Phenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same | |
JPS6126918B2 (en) | ||
JPS6143360B2 (en) | ||
US4292404A (en) | Method for determining the activity of the angiotensin-converting enzyme | |
JPS5827784B2 (en) | amino acid derivative | |
US4774340A (en) | Method for preparing 3-hydroxy pyrroles and esters thereof | |
JPS5850986B2 (en) | Lysine derivative | |
JPS6112898B2 (en) | ||
US4418012A (en) | Leucylalany-arginine derivative | |
JPS593989B2 (en) | Tyrosine derivative | |
US4950593A (en) | Improved method for assaying proteolytic enzymes | |
JPS6029702B2 (en) | arginine derivative | |
US20020120151A1 (en) | Composition and device for detecting leukocytes in urine | |
EP0158226A2 (en) | Method of synthesizing esters | |
US5220029A (en) | Synthetic proteolytic substrate | |
JPS6342638B2 (en) | ||
JP3667470B2 (en) | Method and reagent for measuring acid carboxypeptidase activity |